Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12

Oncogene

Volumn 24, Issue 3, 2005, Pages 489-501

  Teramoto, Hidemi ^a   Castellone, Maria Domenica ^a   Malek, Renae L ^b   Letwin, Noah ^b,c   Frank, Bryan ^b   Gutkind, J Silvio ^a   Lee, Norman H ^b,c  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b J CRAIG VENTER INSTITUTE   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Microarray; NIH3T3; Osteopontin; Ras; RNAi; siRNA

Indexed keywords

HERMES ANTIGEN; OSTEOPONTIN; RAC PROTEIN; RAS PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CANCER INVASION; CELL STRAIN 3T3; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

3T3 CELLS; ANIMALS; ANTIGENS, CD44; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; MICE; MUTATION; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; OSTEOPONTIN; POLYMERASE CHAIN REACTION; RAC1 GTP-BINDING PROTEIN; RAS PROTEINS; RNA, SMALL INTERFERING; SEQUENCE DELETION; SIALOGLYCOPROTEINS; TRANSFECTION;

ANIMALIA;

EID: 13244284603     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208209     Document Type: Article

References (55)

1. Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ and Mercurio AM. (2003). Cancer Res., 63, 5230-5233.
2. Berken A, Abel J and Unfried K. (2003). Oncogene, 22, 8524-8528.
3. Bourguignon LY, Zhu H, Shao L and Chen YW. (2000). J. Biol. Chem., 275, 1829-1838.
4. Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA and Hung MC. (2001). J. Biol. Chem., 276, 48679-48692.
5. Breen EC and Tang K. (2003). J. Cell. Biochem., 88, 848-854.
6. Bug G, Rossmanith T, Henshler R, Kunz-Schughart LA, Schroder B, Kampfmann M, Kreutz M, Hoelzer D and Ottmann OG. (2002). J. Leukoc. Biol., 72, 837-845.
7. Caplen NJ, Parrish S, Imani F, Fire A and Morgan RA. (2001). Proc. Natl. Acad. Sci. USA, 98, 9742-9747.
8. Choi SC, Kim KD, Kim JT, Kim JW, Yoon DY, Choe YK, Chang YS, Paik SG and Lim JS. (2003). FEBS Lett., 553, 413-418.
9. Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P and Ben-Ze'ev A. (2002). Genes. Dev., 16, 2058-2072.
10. Connolly JO, Simpson N, Hewlett L and Hall A. (2002). Mol. Biol. Cell., 13, 2474-2485.
11. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF and Yeatman TJ. (2004). Clin. Cancer Res., 10, 184-190.
12. Crowe DL. (2004). Anticancer Res., 2B, 593-597.
13. Deng Y, Yao L, Chau L, Ng SS, Peng Y, Liu X, Au WS, Wang J, Li F, Ji S, Man H, Nie X, Li Q, Kung HF, Leung SY and Lin MC. (2003). Int. J. Cancer, 106, 342-347.
14. Denhardt DT, Mistretta D, Chambers AF, Krishna S, Porter JF, Raghuram S and Rittling SR. (2003). Clin. Exp. Metast., 20, 77-84.
15. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001). Nature, 411, 428-429.
16. Ellis CA and Clark G. (2000). Cell Signal, 12, 425-434.
17. Feng F and Rittling SR. (2000). Breat Cancer Res. Treat., 63, 71-79.
18. Furger KA, Menon RK, Tuck AB, Bramwell VH and Chambers AF. (2001). Curr. Mol. Med., 1, 621-632.
19. Hosack DA, Dennis Jr G, Sherman BT, Lane HC and Lempcki RA. (2003). Genome Biol., 4, R70.
20. Hu DD, Lin ECK, Kovach NL, Hoyer JR and Smith JW. (1995). J. Biol. Chem., 270, 26232-26238.
21. Katagiri YU, Murakami M, Mori K, Iizuka J, Hara T, Tanaka K, Jia W-J, Chambers AF and Uede T. (1996). J. Cell Biochem., 62, 123-131.
22. Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF and Uede T. (1999). Cancer Res., 59, 219-226.
23. Mahabeleshwar GH, Das R and Kundu GC. (2004). J. Biol. Chem., 279, 9733-9742.
24. Malek RL, Irby RB, Guo QM, Lee K, Wong S, He M, Tsai J, Frank B, Liu ET, Quackenbush J, Jove R, Yeatman TJ and Lee NH. (2002). Oncogene, 21, 7256-7265.
25. Narumiya S. (1996). J. Biochem., 120, 215-228.
26. Novina CD and Sharp PA. (2004). Nature, 430, 161-164.
27. Oates AJ, Barraclough R and Rudland PS. (1996). Oncogene, 13, 97-104.
28. Oates AJ, Barraclough R and Rudland PS. (1997). Invas. Metast., 17, 1-15.
29. Ownby SE and Hohl RJ. (2002). Lipids, 37, 185-192.
30. Pavlidis P and Noble WS. (2001). Genome Biol., 2, research0042.1-0042.15.
31. Qu X, Wei H, Zhai Y, Que H, Chen Q, Tang F, Wu Y, Xing G, Zhu Y, Liu S, Fan M and He F. (2002). J. Biol. Chem., 277, 35574-35585.
32. Rozsnyay Z. (1999). Immunol Lett., 68, 101-108.
33. Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA and Cox AD. (2000). Oncogene, 19, 4685-4694.
34. Sakbe K, Teramoto H, Zohar M, Behbahani B, Miyazaki H, Chikumi H and Gutkind JS. (2002). FEBS Lett., 511, 15-20.
35. Schlessinger J and Bar-Sagi D. (1994). Cold Spring Harb. Symp. Quant. Biol., 59, 173-179.
36. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U and Bell JI. (1992). Proc. Natl. Acad. Sci. USA, 89, 12160-12164.
37. Sehgal A, Ricks S, Warrick J, Boynton AL and Murphy GP. (1999). Anticancer Res., 19, 4947-4953.
38. Servitja JM, Marinissen MJ, Sodhi A, Bustelo XR and Gutkind JS. (2003). J. Biol. Chem., 278, 34339-34346.
39. Sever N, Yang T, Brown MS, Goldstein JL and DeBose-Boyd RA. (2003). Mol. Cell, 11, 25-33.
40. Shiraishi Y, Mizutani A, Bito H, Fujisawa K, Narumiya S, Mikoshiba K and Furuichi T. (1999). J. Neurosci., 19, 8389-8400.
41. Singh RP, Kumar R and Kapur N. (2003). J. Environ. Pathol. Toxicol. Oncol., 22, 75-92.
42. Takai Y, Sasaki T and Matozaki T. (2001). Physiol. Rev., 81, 153-208.
43. Tanaka TS, Jaradat SA, Lim MK, Kargul GJ, Wang X, Grahovac MJ, Pantano S, Sano Y, Piao Y, Nagaraja R, Doi H, Wood III WH, Becker KG and Ko MS. (2000). Proc. Natl. Acad. Sci. USA., 97, 9127-9132.
44. Teramoto H, Malek RL, Behbahani B, Castellone MD, Lee NH and Gutkind JS. (2003). Oncogene, 22, 2689-2697.
45. Teriete P, Banerji S, Noble M, Blundell CD, Wright AJ, Pickford AR, Lowe E, Mahoney DJ, Tammi MI, Kahmann JD, Campbell ID, Day AJ and Jackson DG. (2004). Mol. Cell, 13, 483-496.
46. Troppmair J, Bruder JT, Munoz H, Lloyd PA, Kyrakis J, Banerjee P, Avruch J and Rapp UR. (1994). J. Biol. Chem., 269, 7030-7035.
47. Ue T, Yokozaki H, Kitadai Y, Yamamoto S, Yasui W, Ishikawa T and Tahara E. (1998). Int. J. Cancer, 79, 127-132.
48. Wang L, Schmitz V, Perez-Mediavilla A, Izal I, Prieto J and Qian C. (2003). Mol. Ther., 8, 72-79.
49. Weber GF, Ashkar S, Glimcher MJ and Cantor H. (1996). Science, 271, 509-512.
50. Wes PD, Yu M and Montell C. (1996). EMBO J., 15, 5839-5848.
51. Wu W, Wong K, Chen J, Jiang Z, Dupuis S, Wu JY and Rao Y. (1999). Nature, 400, 331-336.
52. Wu Y, Denhardt DT and Rittling SR. (2000). Br. J. Cancer, 82, 156-163.
53. Yue TL, McKenna PJ, Ohlstein EH, Farach-Carson MC, Butler WT, Johanson K, McDevitt P, Feuerstein GZ and Stadel JM. (1994). Exp. Cell Res., 214, 459-464.
54. Zhang J, Takahashi K, Takahashi F, Shimizu K, Ohshita F, Kameda Y, Maeda K, Nishio K and Fukuchi Y. (2001). Cancer Lett., 171, 215-222.
55. Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M, Sers C, Rosen thai A and Schafer R. (2000). Nat. Genet., 24, 144-152.